Top compounds associated with response to MT-ND2


Feature Type Standardized
Nominal ANOVA
mRNA SID 26681509 CTRPv2 pan-cancer AAC -0.1 0.01
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.086 0.01
mRNA neratinib CTRPv2 pan-cancer AAC 0.092 0.02
mRNA AZD4547 CTRPv2 pan-cancer AAC -0.098 0.02
mRNA AZD6244 CTRPv2 pan-cancer AAC 0.093 0.02
mRNA TG-101348 CTRPv2 pan-cancer AAC -0.085 0.02
mRNA AT7867 CTRPv2 pan-cancer AAC -0.089 0.02
mRNA lapatinib CTRPv2 pan-cancer AAC 0.09 0.02
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.09 0.02
mRNA Vandetanib CTRPv2 pan-cancer AAC 0.09 0.02
Download CSV